secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0000950170-23-000285
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Dec 30, 2022 for non-compliance with $1.00 minimum bid price requirement.
- Has 180 calendar days (until June 28, 2023) to regain compliance by closing at $1.00+ for 10 consecutive days.
- May be eligible for additional 180-day extension if it transfers listing to Nasdaq Capital Market.
- Company may consider a reverse stock split to regain compliance, subject to board and shareholder approval.
- No assurance compliance will be regained; failure could lead to delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000095017023000285/0000950170-23-000285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000095017023000285/fnch-20230106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer